Advertisement
Screener

ARDELYX, INC. (ARDX) Patents: Active

ARDELYX, INC. Active Patents

38 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2023-12-27: Application 18397454; Invention COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS; Applicant Ardelyx, Inc.; Status Patented Case.
  • 2022-07-06: Application 17858917; Invention HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS; Applicant ARDELYX, INC.; Status Patented Case.
  • 2022-04-01: Application 17711863; Invention COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS; Applicant Ardelyx, Inc.; Status Patented Case.
  • 2021-08-09: Application 17429599; Invention GLYCYRRHETINIC ACID DERIVATIVES FOR USE IN TREATING HYPERKALEMIA; Applicant ARDELYX, INC.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2023-12-2718397454COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERSArdelyx, Inc.Patented Case2025-04-2212281103US20240317719A1
Dean DRAGOLI
Irina DOTSENKO
Jason LEWIS
United States
United States
United States
SEAMAN, D MARGARET M
2022-07-0617858917HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERSARDELYX, INC.Patented Case2025-01-2812209088US20230139597A1
Jianhua Chao
Rakesh Jain
Lily Hu
Jason Gustaf Lewis
Helene Baribault
Jeremy Caldwell
United States
United States
United States
United States
United States
United States
KENYON, JOHN S
2022-04-0117711863COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERSArdelyx, Inc.Patented Case2024-06-2512016856US20230031776A1
Dominique Charmot
Marc Navre
Christopher Carreras
Noah Bell
Michael Leadbetter
Jeffrey W. Jacobs
United States
United States
United States
United States
United States
United States
GREENE, IVAN A
2021-08-0917429599GLYCYRRHETINIC ACID DERIVATIVES FOR USE IN TREATING HYPERKALEMIAARDELYX, INC.Patented Case2024-01-0211858959US20220106354A1
Dean Dragoli
Gary Luehr
Tao Chen
Jason Lewis
Michael Leadbetter
United States
United States
United States
United States
United States
HOWELL, THEODORE R
2021-04-0717224518ISOXAZOLYL-CARBONYLOXY AZABICYCLO[3.2.1]OCTANYL COMPOUNDS AS FXR ACTIVATORSARDELYX, INC.Patented Case2023-08-0811718619US20210300927A1
Jianhua Chao
Rakesh Jain
Lily Hu
Jason Gustaf Lewis
Helene Baribault
Jeremy Caldwell
United States
United States
United States
United States
United States
United States
CHANDRAKUMAR, NIZAL S
2021-02-2517185653SUBSTITUTED 4-PHENYL PYRIDINE COMPOUNDS AS NON-SYSTEMIC TGR5 AGONISTSArdelyx, Inc.Patented Case2024-09-1012084472US20220306672A1
Jason G. Lewis
Michael Robert Leadbetter
Jeremy Caldwell
Dean Dragoli
Noah Bell
Jeffrey W. Jacobs
Patricia Finn
Rakesh Jain
Tao Chen
Matthew Siegel
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
WITHERSPOON, SIKARL A
2020-03-1316647385HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC MUTAGENIC AND FIBROTIC CONDITIONS AND DISORDERSArdelyx, Inc.Patented Case2023-09-1211753410US20210380585A1
Jianhua Chao
United States
KIFLE, BRUCK
2020-02-0416636596GLYCYRRHETINIC ACID DERIVATIVES FOR TREATING HYPERKALEMIAArdelyx, Inc.Patented Case2023-09-2611768319US20210163524A1
Gary Luehr
Dean Dragoli
Michael Leadbetter
Tao Chen
Jason Lewis
United States
United States
United States
United States
United States
MOORE, SUSANNA
2020-01-2716773723COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERSArdelyx, Inc.Patented Case2022-05-0311318129US20200268741A1
Dominique Charmot
Marc Navre
Christopher Carreras
Noah Bell
Michael Robert Leadbetter
Jeffrey W. Jacobs
United States
United States
United States
United States
United States
United States
GREENE, IVAN A
2019-07-1516512210COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORTArdelyx, Inc.Patented Case2023-11-1411813304US20200038475A1
Dominique Charmot
Jason G. Lewis
Jeffrey W. Jacobs
Ingrid Langsetmo
Christopher Carreras
United States
United States
United States
United States
United States
AUDET, MAURY A
2019-07-0916476836COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERSArdelyx, Inc.Patented Case2022-02-0811242337US20190359599A1
Dean DRAGOLI
Irina DOTSENKO
Jason LEWIS
United States
United States
United States
SEAMAN, D MARGARET M
2019-07-0916476835INHIBITORS OF NHE-MEDIATED ANTIPORTArdelyx, Inc.Patented Case2021-10-1911147884US20190374649A1
Irina DOTSENKO
Dean DRAGOLI
Jason LEWIS
United States
United States
United States
MAURO, JOHN MATTHEW
2019-06-2816456661SUBSTITUTED 4-PHENYL PYRIDINE COMPOUNDS AS NON-SYSTEMIC TGR5 AGONISTSArdelyx, Inc.Patented Case2021-04-0610968246US20200062795A1
Jason G. Lewis
Michael Robert Leadbetter
Jeremy Caldwell
Dean Dragoli
Noah Bell
Jeffrey W. Jacobs
Patricia Finn
Rakesh Jain
Tao Chen
Matthew Siegel
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
REESE, HEIDI L
2019-03-1216351225NHE3-BINDING COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORTArdelyx, Inc.Patented Case2021-03-0910940146US20190275028A1
Christopher Carreras
Dominique Charmot
Jeffrey W. Jacobs
Eric Labonte
Jason G. Lewis
United States
United States
United States
United States
United States
REESE, HEIDI L
2019-02-2216327791HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERSARDELYX, INC.Patented Case2020-10-0610793568US20190233420A1
Jianhua Chao
Rakesh Jain
Lily Hu
Jason Gustaf Lewis
Helene Baribault
Jeremy Caldwell
United States
United States
United States
United States
United States
United States
KENYON, JOHN S
2019-02-2216327790ISOXAZOLYL-CARBONYLOXY AZABICYCLO[3.2.1]OCTANYL COMPOUNDS AS FXR ACTIVATORSARDELYX, INC.Patented Case2021-08-1711091482US20190308973A1
Jianhua Chao
Rakesh Jain
Lily Hu
Jason Gustaf Lewis
Helene Baribault
Jeremy Caldwell
United States
United States
United States
United States
United States
United States
CHANDRAKUMAR, NIZAL S
2018-06-1316007622COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERSArdelyx, Inc.Patented Case2019-08-2010385024US20190062279A1
Noah BELL
Christopher CARRERAS
Dominique CHARMOT
Tao CHEN
Michael LEADBETTER
Jeffrey JACOBS
Jason LEWIS
United States
United States
United States
United States
United States
United States
United States
REESE, HEIDI L
2017-03-2915472936COMPOSITIONS AND METHODS FOR TREATING HYPERKALEMIAArdelyx, Inc.Patented Case2018-01-169867848US20170196903A1
Dominique Charmot
James P. Davidson
Fangling Lin
Jeffrey W. Jacobs
Natalia Blinova
Eric Labonte
Ingrid Langsetmo
Robert C. Blanks
United States
United States
United States
United States
United States
United States
United States
United States
ROSENTHAL, ANDREW S
2017-01-0915402213COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERSARDELYX, INCPatented Case2019-08-1310376481US20170368004A1
Noah BELL
Christopher CARRERAS
Michael Robert LEADBETTER
Jason Gustaf LEWIS
Jeffrey W. JACOBS
Irina DOTSENKO
Dean DRAGOLI
Ying HE
Andrew KING
Matthew SIEGEL
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
HEYER, DENNIS
2017-01-0915402211COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERSARDELYX, INC.Patented Case2020-01-2810543207US20170340623A1
Dominique CHARMOT
Marc NAVRE
Christopher CARRERAS
Noah BELL
Michael Robert LEADBETTER
Jeffrey W. JACOBS
United States
United States
United States
United States
United States
United States
GREENE, IVAN A
2016-12-1915382872SUBSTITUTED 4-PHENYL PYRIDINE COMPOUNDS AS NON-SYSTEMIC TGR5 AGONISTSArdelyx, Inc.Patented Case2019-08-2710392413US20170174718A1
Jason Gustaf LEWIS
Michael Robert LEADBETTER
Jeremy CALDWELL
Dean DRAGOLI
Noah BELL
Jeffrey W. JACOBS
Patricia FINN
Rakesh JAIN
Tao CHEN
Matthew SIEGEL
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
REESE, HEIDI L
2016-07-2915223798COMPOSITIONS AND METHODS FOR TREATING HYPERKALEMIAArdelyx, Inc.Patented Case2018-03-209919006US20170173072A1
Dominique Charmot
James P. Davidson
Fangling Lin
Jeffrey W. Jacobs
Natalia Blinova
Eric Labonte
Ingrid Langsetmo
Robert C. Blanks
United States
United States
United States
United States
United States
United States
United States
United States
ROSENTHAL, ANDREW S
2016-02-2415052193PHARMACEUTICAL COMPOSITIONS FOR TREATING HYPERKALEMIAArdelyx, Inc.Patented Case2017-01-249549947US20160175346A1
Dominique Charmot
James P. Davidson
Fangling Lin
Jeffrey W. Jacobs
Natalia Blinova
Eric Labonte
Ingrid Langsetmo
Robert C. Blanks
United States
United States
United States
United States
United States
United States
United States
United States
ROSENTHAL, ANDREW S
2016-02-2415052190PHARMACEUTICAL COMPOSITIONS FOR TREATING HYPERKALEMIAArdelyx, Inc.Patented Case2017-01-179545425US20160175345A1
Dominique Charmot
James P. Davidson
Fangling Lin
Jeffrey W. Jacobs
Natalia Blinova
Eric Labonte
Ingrid Langsetmo
Robert C. Blanks
United States
United States
United States
United States
United States
United States
United States
United States
ROSENTHAL, ANDREW S
2016-02-2415052186COMPOSITIONS AND METHODS FOR TREATING HYPERKALEMIAArdelyx, Inc.Patented Case2016-09-069433640US20160175344A1
Dominique Charmot
James P. Davidson
Fangling Lin
Jeffrey W. Jacobs
Natalia Blinova
Eric Labonte
Ingrid Langsetmo
Robert C. Blanks
United States
United States
United States
United States
United States
United States
United States
United States
ROSENTHAL, ANDREW S
2016-02-1814912682COMPOSITIONS AND METHODS FOR TREATING HYPERKALEMIAARDELYX, INC.Patented Case2017-05-239655921US20160346318A1
Dominique Charmot
James P. Davidson
Fangling Lin
Jeffrey W. Jacobs
Natalia Blinova
Eric Labonte
Ingrid Langsetmo
Robert C. Blanks
United States
United States
United States
United States
United States
United States
United States
United States
ROSENTHAL, ANDREW S
2015-10-1214783983NHE3-BINDING COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORTARDELYX, INCPatented Case2019-04-3010272079US20160067242A1
Christopher Carreras
Dominique Charmot
Jeffrey W Jacobs
Eric Labonte
Jason G. Lewis
United States
United States
United States
United States
United States
REESE, HEIDI L
2015-01-0814592200COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERArdelyx, Inc.Patented Case2016-08-099408840US20150190389A1
Noah BELL
Christopher CARRERAS
Dominique CHARMOT
Jeffrey W. JACOBS
Michael Robert LEADBETTER
Marc NAVRE
United States
United States
United States
United States
United States
United States
GREENE, IVAN A
2014-11-0714536509COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORTArdelyx, Inc.Patented Case2016-04-059301951US20150164876A1
Jason G. Lewis
Jeffrey W. Jacobs
Nicholas Reich
Michael R. Leadbetter
Noah Bell
Han-Ting Chang
Tao Chen
Marc Navre
Dominique Charmot
Christopher Carreras
Eric Labonte
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
BARKER, MICHAEL P
2014-07-2114337032COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORTArdelyx, Inc.Patented Case2016-03-089278102US20150164905A1
Jason G. Lewis
Jeffrey W. Jacobs
Nicholas Reich
Michael R. Leadbetter
Noah Bell
Han-Ting Chang
Tao Chen
Marc Navre
Dominique Charmot
Christopher Carreras
Eric Labonte
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
BARKER, MICHAEL P
2014-07-2114337028COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORTArdelyx, Inc.Patented Case2016-03-229289430US20150164904A1
Jason G. Lewis
Jeffrey W. Jacobs
Nicholas Reich
Michael R. Leadbetter
Noah Bell
Han-Ting Chang
Tao Chen
Marc Navre
Dominique Charmot
Christopher Carreras
Eric Labonte
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
BARKER, MICHAEL P
2014-07-1114329821COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORTArdelyx, Inc.Patented Case2016-03-229289429US20150157637A1
Jason G. Lewis
Jeffrey W. Jacobs
Nicholas Reich
Michael R. Leadbetter
Noah Bell
Han-Ting Chang
Tao Chen
Marc Navre
Dominique Charmot
Christopher Carreras
Eric Labonte
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
BARKER, MICHAEL P
2013-03-1413826186COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERSArdelyx, Inc.Patented Case2015-04-149006281US20130274285A1
Noah BELL
Christopher CARRERAS
Dominique CHARMOT
Jeffrey W. JACOBS
Michael Robert LEADBETTER
Marc NAVRE
United States
United States
United States
United States
United States
United States
GREENE, IVAN A
2013-03-1413804752COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERSArdelyx, Inc.Patented Case2015-03-038969377US20140107074A1
Noah BELL
Christopher CARRERAS
Dominique CHARMOT
Jeffrey W. JACOBS
Michael Robert LEADBETTER
Marc NAVRE
United States
United States
United States
United States
United States
United States
GREENE, IVAN A
2013-01-0413734701COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORTArdelyx, Inc.Patented Case2014-08-268815908US20130336919A1
Jason G. Lewis
Jeffrey W. Jacobs
Nicholas Reich
Michael R. Leadbetter
Noah Bell
Han-Ting Chang
Tao Chen
Marc Navre
Dominique Charmot
Christopher Carreras
Eric Labonte
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
BARKER, MICHAEL P
2013-01-0413734562COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORTArdelyx, Inc.Patented Case2014-08-268815910US20130336921A1
Jason G. Lewis
Jeffrey W. Jacobs
Nicholas Reich
Michael R. Leadbetter
Noah Bell
Han-Ting Chang
Tao Chen
Marc Navre
Dominique Charmot
Christopher Carreras
Eric Labonte
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
BARKER, MICHAEL P
2013-01-0413734551COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORTArdelyx, Inc.Patented Case2014-08-198809339US20130336918A1
Jason G. Lewis
Jeffrey W. Jacobs
Nicholas Reich
Michael R. Leadbetter
Noah Bell
Han-Ting Chang
Tao Chen
Marc Navre
Dominique Charmot
Christopher Carreras
Eric Labonte
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
BARKER, MICHAEL P
2013-01-0413734547COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORTArdelyx, Inc.Patented Case2014-12-238916569US20130336920A1
Jason G. Lewis
Jeffrey W. Jacobs
Nicholas Reich
Michael R. Leadbetter
Noah Bell
Han-Ting Chang
Tao Chen
Marc Navre
Dominique Charmot
Christopher Carreras
Eric Labonte
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
BARKER, MICHAEL P

Similar stocks

Stock NameCountryMarket CapPE Ratio
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Cryoport, Inc. (CYRX)United States$0.881B-21.29
Theravance Biopharma, Inc. (TBPH)$0.885B16.40
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
Apnimed, Inc. (APMD)United States$0.899B
GERON CORP (GERN)United States$0.803B-12.14